GREY:MDCGF - Post by User
Post by
victor16on Jan 26, 2011 2:20pm
346 Views
Post# 18029919
amgen effect ?
amgen effect ?26 Jan 2011
...Amgen, a human therapeutics company that focuses on advances in recombinant DNA will be acquiring BioVex Group for $1 billion
BioVex’s lead product, the experimental cancer vaccine Oncovex, is in the final stages of testing usually required for regulatory approval. It treats metastatic melanoma, a skin cancer. The drug also is being studied in head and neck cancer, the companies said.
at 78 millions mdg is cheap